Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Conditions
- Generalized Anxiety Disorder
Interventions
- DRUG: Buagafuran capsules, 15mg/ capsule
- DRUG: Buspirone tablets, 5mg/ tablet
- DRUG: Buagafuran capsules mimic, 0mg/ capsule
- DRUG: Buspirone tablets mimic, 0mg/ tablet
Sponsor
Beijing Union Pharmaceutical Factory Ltd
Collaborators